Advanced search
Publication Cover
Renal Failure Volume 42, 2020 - Issue 1
Submit an article Journal homepage
2,031
Views
18
CrossRef citations to date
0
Altmetric
Clinical Study

Association of trimethylamine N-Oxide with cardiovascular and all-cause mortality in hemodialysis patients

Pan Zhanga Department of Nephrology, Zhongshan Hospital, Fudan University, Shanghai, China;b Hemodialysis Quality Control Center of Shanghai, Shanghai, China;c Shanghai Key Laboratory of Kidney and Blood Purification, Shanghai, China;d Shanghai Institute for Kidney and Dialysis, Shanghai, China;e Shanghai Clinical Medical Center for Kidney Disease, Shanghai, ChinaView further author information
,
Jian-Zhou Zoua Department of Nephrology, Zhongshan Hospital, Fudan University, Shanghai, China;b Hemodialysis Quality Control Center of Shanghai, Shanghai, China;c Shanghai Key Laboratory of Kidney and Blood Purification, Shanghai, China;d Shanghai Institute for Kidney and Dialysis, Shanghai, China;e Shanghai Clinical Medical Center for Kidney Disease, Shanghai, ChinaView further author information
,
Jun Chenf Department of Pharmaceutics, School of Pharmacy, Fudan University, Shanghai, ChinaView further author information
,
Xiao Tana Department of Nephrology, Zhongshan Hospital, Fudan University, Shanghai, China;b Hemodialysis Quality Control Center of Shanghai, Shanghai, China;c Shanghai Key Laboratory of Kidney and Blood Purification, Shanghai, China;d Shanghai Institute for Kidney and Dialysis, Shanghai, China;e Shanghai Clinical Medical Center for Kidney Disease, Shanghai, ChinaView further author information
,
Fang-Fang Xianga Department of Nephrology, Zhongshan Hospital, Fudan University, Shanghai, China;b Hemodialysis Quality Control Center of Shanghai, Shanghai, China;c Shanghai Key Laboratory of Kidney and Blood Purification, Shanghai, China;d Shanghai Institute for Kidney and Dialysis, Shanghai, China;e Shanghai Clinical Medical Center for Kidney Disease, Shanghai, ChinaView further author information
,
Bo Shena Department of Nephrology, Zhongshan Hospital, Fudan University, Shanghai, China;b Hemodialysis Quality Control Center of Shanghai, Shanghai, China;c Shanghai Key Laboratory of Kidney and Blood Purification, Shanghai, China;d Shanghai Institute for Kidney and Dialysis, Shanghai, China;e Shanghai Clinical Medical Center for Kidney Disease, Shanghai, ChinaView further author information
,
Jia-Chang Hua Department of Nephrology, Zhongshan Hospital, Fudan University, Shanghai, China;b Hemodialysis Quality Control Center of Shanghai, Shanghai, China;c Shanghai Key Laboratory of Kidney and Blood Purification, Shanghai, China;d Shanghai Institute for Kidney and Dialysis, Shanghai, China;e Shanghai Clinical Medical Center for Kidney Disease, Shanghai, ChinaView further author information
,
Jia-Lin Wanga Department of Nephrology, Zhongshan Hospital, Fudan University, Shanghai, China;b Hemodialysis Quality Control Center of Shanghai, Shanghai, China;c Shanghai Key Laboratory of Kidney and Blood Purification, Shanghai, China;d Shanghai Institute for Kidney and Dialysis, Shanghai, China;e Shanghai Clinical Medical Center for Kidney Disease, Shanghai, ChinaView further author information
,
Ya-Qiong Wanga Department of Nephrology, Zhongshan Hospital, Fudan University, Shanghai, China;b Hemodialysis Quality Control Center of Shanghai, Shanghai, China;c Shanghai Key Laboratory of Kidney and Blood Purification, Shanghai, China;d Shanghai Institute for Kidney and Dialysis, Shanghai, China;e Shanghai Clinical Medical Center for Kidney Disease, Shanghai, ChinaView further author information
,
Jin-Bo Yua Department of Nephrology, Zhongshan Hospital, Fudan University, Shanghai, China;b Hemodialysis Quality Control Center of Shanghai, Shanghai, China;c Shanghai Key Laboratory of Kidney and Blood Purification, Shanghai, China;d Shanghai Institute for Kidney and Dialysis, Shanghai, China;e Shanghai Clinical Medical Center for Kidney Disease, Shanghai, ChinaView further author information
,
Yu-Xin Niea Department of Nephrology, Zhongshan Hospital, Fudan University, Shanghai, China;b Hemodialysis Quality Control Center of Shanghai, Shanghai, China;c Shanghai Key Laboratory of Kidney and Blood Purification, Shanghai, China;d Shanghai Institute for Kidney and Dialysis, Shanghai, China;e Shanghai Clinical Medical Center for Kidney Disease, Shanghai, ChinaView further author information
,
Xiao-Hong Chena Department of Nephrology, Zhongshan Hospital, Fudan University, Shanghai, China;b Hemodialysis Quality Control Center of Shanghai, Shanghai, China;c Shanghai Key Laboratory of Kidney and Blood Purification, Shanghai, China;d Shanghai Institute for Kidney and Dialysis, Shanghai, China;e Shanghai Clinical Medical Center for Kidney Disease, Shanghai, ChinaView further author information
,
Jia-Wei Yua Department of Nephrology, Zhongshan Hospital, Fudan University, Shanghai, China;b Hemodialysis Quality Control Center of Shanghai, Shanghai, China;c Shanghai Key Laboratory of Kidney and Blood Purification, Shanghai, China;d Shanghai Institute for Kidney and Dialysis, Shanghai, China;e Shanghai Clinical Medical Center for Kidney Disease, Shanghai, ChinaView further author information
,
Zhen Zhanga Department of Nephrology, Zhongshan Hospital, Fudan University, Shanghai, China;b Hemodialysis Quality Control Center of Shanghai, Shanghai, China;c Shanghai Key Laboratory of Kidney and Blood Purification, Shanghai, China;d Shanghai Institute for Kidney and Dialysis, Shanghai, China;e Shanghai Clinical Medical Center for Kidney Disease, Shanghai, ChinaView further author information
,
Wen-Lv Lva Department of Nephrology, Zhongshan Hospital, Fudan University, Shanghai, China;b Hemodialysis Quality Control Center of Shanghai, Shanghai, China;c Shanghai Key Laboratory of Kidney and Blood Purification, Shanghai, China;d Shanghai Institute for Kidney and Dialysis, Shanghai, China;e Shanghai Clinical Medical Center for Kidney Disease, Shanghai, ChinaView further author information
,
Ye-Qing Xiea Department of Nephrology, Zhongshan Hospital, Fudan University, Shanghai, China;b Hemodialysis Quality Control Center of Shanghai, Shanghai, China;c Shanghai Key Laboratory of Kidney and Blood Purification, Shanghai, China;d Shanghai Institute for Kidney and Dialysis, Shanghai, China;e Shanghai Clinical Medical Center for Kidney Disease, Shanghai, ChinaView further author information
,
Xue-Sen Caoa Department of Nephrology, Zhongshan Hospital, Fudan University, Shanghai, China;b Hemodialysis Quality Control Center of Shanghai, Shanghai, China;c Shanghai Key Laboratory of Kidney and Blood Purification, Shanghai, China;d Shanghai Institute for Kidney and Dialysis, Shanghai, China;e Shanghai Clinical Medical Center for Kidney Disease, Shanghai, ChinaCorrespondence[email protected]
View further author information
&
Xiao-Qiang Dinga Department of Nephrology, Zhongshan Hospital, Fudan University, Shanghai, China;b Hemodialysis Quality Control Center of Shanghai, Shanghai, China;c Shanghai Key Laboratory of Kidney and Blood Purification, Shanghai, China;d Shanghai Institute for Kidney and Dialysis, Shanghai, China;e Shanghai Clinical Medical Center for Kidney Disease, Shanghai, ChinaCorrespondence[email protected]
View further author information
 show all
Pages 1004-1014 | Received 01 Jun 2020, Accepted 07 Sep 2020, Published online: 27 Sep 2020

References

  • United States Renal Data System. 2018 USRDS annual data report: Epidemiology of kidney disease in the United States. Bethesda (MD): National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2018.
  • Himmelfarb J, Ikizler TA. Hemodialysis. N Engl J Med. 2010;363(19):1833–1845.
  • Longenecker JC, Coresh J, Powe NR, et al. Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study. J Am Soc Nephrol. 2002;13(7):1918–1927.
  • Tomlinson JAP, Wheeler DC. The role of trimethylamine N-oxide as a mediator of cardiovascular complications in chronic kidney disease. Kidney Int. 2017;92(4):809–815.
  • Cao XS, Chen J, Zou JZ, et al. Association of indoxyl sulfate with heart failure among patients on hemodialysis. CJASN. 2015;10(1):111–119.
  • Meijers BK, Bammens B, De Moor B, et al. Free p-cresol is associated with cardiovascular disease in hemodialysis patients. Kidney Int. 2008;73(10):1174–1180.
  • Meyer TW, Hostetter TH. Approaches to Uremia. J Am Soc Nephrol. 2014;25(10):2151–2158.
  • Wang Z, Klipfell E, Bennett BJ, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011;472(7341):57–63.
  • Tang WH, Wang Z, Levison BS, et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med. 2013;368(17):1575–1584.
  • Zhu W, Gregory JC, Org E, et al. Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk. Cell. 2016;165(1):111–124.
  • Seldin MM, Meng Y, Qi H, et al. Trimethylamine N-oxide promotes vascular inflammation through signaling of mitogen-activated protein kinase and nuclear factor-kappaB. J Am Heart Assoc. 2016;5(2):12.
  • Sun XL, Jiao XF, Ma YR, et al. Trimethylamine N-oxide induces inflammation and endothelial dysfunction in human umbilical vein endothelial cells via activating ROS-TXNIP-NLRP3 inflammasome. Biochem Biophys Res Commun. 2016;481(1–2):63–70.
  • Chen ML, Zhu XH, Ran L, et al. Trimethylamine-N-oxide induces vascular inflammation by activating the NLRP3 inflammasome through the SIRT3-SOD2-mtROS signaling pathway. J Am Heart Assoc. 2017;6(9):21.
  • Chen S, Henderson A, Petriello MC, et al. Trimethylamine N-oxide binds and activates PERK to promote metabolic dysfunction. Cell Metab. 2019;30(6):1141–1151.e1145.
  • Stubbs JR, House JA, Ocque AJ, et al. Serum trimethylamine-N-oxide is elevated in CKD and correlates with coronary atherosclerosis burden. JASN. 2016;27(1):305–313.
  • Kim RB, Morse BL, Djurdjev O, et al. Advanced chronic kidney disease populations have elevated trimethylamine N-oxide levels associated with increased cardiovascular events. Kidney Int. 2016;89(5):1144–1152.
  • Tang WH, Wang Z, Kennedy DJ, et al. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease. Circ Res. 2015;116(3):448–455.
  • Hai X, Landeras V, Dobre MA, et al. Mechanism of prominent trimethylamine oxide (TMAO) accumulation in hemodialysis patients. PLoS One. 2015;10(12):e0143731.
  • Kaysen GA, Johansen KL, Chertow GM, et al. Associations of trimethylamine N-oxide with nutritional and inflammatory biomarkers and cardiovascular outcomes in patients new to dialysis. J Ren Nutr. 2015;25(4):351–356.
  • Stubbs JR, Stedman MR, Liu S, et al. Trimethylamine N-oxide and cardiovascular outcomes in patients with ESKD receiving maintenance hemodialysis. Clin J Am Soc Nephrol. 2019;14(2):261–267.
  • Shafi T, Powe NR, Meyer TW, et al. Trimethylamine N-oxide and cardiovascular events in hemodialysis patients. J Am Soc Nephrol. 2017;28(1):321–331.
  • Depner TA, Daugirdas JT. Equations for normalized protein catabolic rate based on two-point modeling of hemodialysis urea kinetics. J Am Soc Nephrol. 1996;7(5):780–785.
  • Meyer TW, Sirich TL, Hostetter TH. Dialysis cannot be dosed. Semin Dial. 2011;24(5):471–479.
  • Depner TA. Uremic toxicity: urea and beyond. Semin Dial. 2001;14(4):246–251.
  • Eknoyan G, Beck GJ, Cheung AK, Hemodialysis (HEMO) Study Group, et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med. 2002;347(25):2010–2019.
  • Wang ZN, Zhao YZ. Gut microbiota derived metabolites in cardiovascular health and disease. Protein Cell. 2018;9(5):416–431.
  • Koeth RA, Wang ZE, Levison BS, et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med. 2013;19(5):576–585.
  • Bain MA, Faull R, Fornasini G, et al. Accumulation of trimethylamine and trimethylamine-N-oxide in end-stage renal disease patients undergoing haemodialysis. Nephrol Dial Transplant. 2006;21(5):1300–1304.
  • Wang Z, Roberts AB, Buffa JA, et al. Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis. Cell. 2015;163(7):1585–1595.
  • Wu IW, Hsu KH, Hsu HJ, et al. Serum free p-cresyl sulfate levels predict cardiovascular and all-cause mortality in elderly hemodialysis patients-a prospective cohort study. Nephrol Dial Transplant. 2012;27(3):1169–1175.
  • Vanholder R, Schepers E, Pletinck A, et al. The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: a systematic review. J Am Soc Nephrol. 2014;25(9):1897–1907.
  • Lekawanvijit S, Adrahtas A, Kelly DJ, et al. Does indoxyl sulfate, a uraemic toxin, have direct effects on cardiac fibroblasts and myocytes? Eur Heart J. 2010;31(14):1771–1779.
  • Flythe JE, Hostetter TH. Assessing clinical relevance of uremic toxins. Clin J Am Soc Nephrol. 2019;14(2):182–183.
  • Chertow GM, Block GA, Correa-Rotter R, et al. Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. N Engl J Med. 2012;367(26):2482–2494.
  • Zheng Y, Tang Z, You L, et al. Trimethylamine-N-oxide is an independent risk factor for hospitalization events in patients receiving maintenance hemodialysis. Ren Fail. 2020;42(1):580–586.
  • Shimizu S, Fukuma S, Ikenoue T, et al. Increased mortality rate after hospitalization among chronic hemodialysis patients: a prospective cohort study. Nephron. 2018;140(3):194–202.
  • Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352(16):1685–1695.
  • Libby P, Ridker PM, Hansson GK,. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol. 2009;54(23):2129–2138.
  • Ridker PM, Everett BM, Pradhan A, et al. Low-dose methotrexate for the prevention of atherosclerotic events. N Engl J Med. 2019;380(8):752–762.
  • Ridker PM, MacFadyen JG, Everett BM, et al. Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial. Lancet. 2018;391(10118):319–328.
  • Zimmermann J, Herrlinger S, Pruy A, et al. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int. 1999;55(2):648–658.
  • Yeun JY, Levine RA, Mantadilok V, et al. C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis. 2000;35(3):469–476.
  • Qureshi AR, Alvestrand A, Divino JC, et al. Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients. J Am Soc Nephrol. 2002;13(1):S28–S36.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.